| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.007 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.008 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |